HUBB vs TELO · P/E 28, rev $1.49B vs $86.0M cap
Hubbell Inc (HUBB) versus Telomir Pharmaceuticals, Inc. Common Stock (TELO) — a side-by-side from cached financials, not a winner call.
Hubbell Inc (HUBB) is a electrical equipment & parts company listed on US.
Telomir Pharmaceuticals, Inc. Common Stock (TELO) is a biotechnology company listed on NASDAQ.
Latest reported HUBB revenue for 2025-12-31 was $1.49B. Net income was $224.2M. Revenue was down 73.5% from 2024-12-31 to 2025-12-31. HUBB currently screens at market cap $22.14B and trailing P/E 28.0.
TELO does not have a complete income-statement cache yet.
HUBB currently screens at market cap $22.14B and trailing P/E 28.0. TELO currently screens at market cap $86.0M.
Not investment advice. Open the HUBB and TELO stock pages for the full models.
Not investment advice.